Publication:
DIAGNOSIS AND COMPLICATION RISK ASSESSMENT OF DIABETES MELLITUS WITHIN NORMAL VALUE RANGES OF LEUCOCYTES USING PROCALCITONIN

dc.contributor.authorsSoylemez, M.
dc.date.accessioned2022-03-10T17:53:25Z
dc.date.accessioned2026-01-11T10:24:32Z
dc.date.available2022-03-10T17:53:25Z
dc.date.issued2015
dc.identifier.doidoiWOS:000349317500243
dc.identifier.eissn1557-8593
dc.identifier.issn1520-9156
dc.identifier.urihttps://hdl.handle.net/11424/221700
dc.identifier.wosWOS:000349317500243
dc.language.isoeng
dc.publisherMARY ANN LIEBERT, INC
dc.relation.ispartofDIABETES TECHNOLOGY & THERAPEUTICS
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleDIAGNOSIS AND COMPLICATION RISK ASSESSMENT OF DIABETES MELLITUS WITHIN NORMAL VALUE RANGES OF LEUCOCYTES USING PROCALCITONIN
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.endPageA107
oaire.citation.startPageA107
oaire.citation.titleDIABETES TECHNOLOGY & THERAPEUTICS
oaire.citation.volume17

Files